These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 34180245)

  • 21. Associations of telomere length with anthropometric and glucose changes after a lifestyle intervention in abdominal obese children.
    Morell-Azanza L; Ojeda-Rodríguez A; Azcona-SanJulián MC; Zalba G; Marti A
    Nutr Metab Cardiovasc Dis; 2020 Apr; 30(4):694-700. PubMed ID: 32007334
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Midregional proatrial natriuretic peptide improves risk stratification after ischemic stroke.
    De Marchis GM; Schneider J; Weck A; Fluri F; Fladt J; Foerch C; Mueller B; Luft A; Christ-Crain M; Arnold M; Katan M
    Neurology; 2018 Feb; 90(6):e455-e465. PubMed ID: 29321236
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Short-Term Influence of Radiofrequency Ablation on NT-proBNP, MR-proANP, Copeptin, and MR-proADM in Patients With Atrial Fibrillation: Data From the Observational SMURF Study.
    Charitakis E; Walfridsson H; Alehagen U
    J Am Heart Assoc; 2016 Sep; 5(9):. PubMed ID: 27633393
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of midregional pro-A-type natriuretic peptide and the N-terminal pro-B-type natriuretic peptide for predicting mortality and cardiovascular events.
    van Hateren KJ; Alkhalaf A; Kleefstra N; Groenier KH; de Jong PE; de Zeeuw D; Gans RO; Struck J; Bilo HJ; Gansevoort RT; Bakker SJ
    Clin Chem; 2012 Jan; 58(1):293-7. PubMed ID: 21948291
    [TBL] [Abstract][Full Text] [Related]  

  • 25. NT-proANP and BNP in renovascular and in severe and mild essential hypertension.
    Mussalo H; Vanninen E; Ikäheimo R; Hartikainen J
    Kidney Blood Press Res; 2003; 26(1):34-41. PubMed ID: 12697975
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Midregional pro-A-type natriuretic peptide measurements for diagnosis of acute destabilized heart failure in short-of-breath patients: comparison with B-type natriuretic peptide (BNP) and amino-terminal proBNP.
    Gegenhuber A; Struck J; Poelz W; Pacher R; Morgenthaler NG; Bergmann A; Haltmayer M; Mueller T
    Clin Chem; 2006 May; 52(5):827-31. PubMed ID: 16543387
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influence of age, race, sex, and body mass index on interpretation of midregional pro atrial natriuretic peptide for the diagnosis of acute heart failure: results from the BACH multinational study.
    Daniels LB; Clopton P; Potocki M; Mueller C; McCord J; Richards M; Hartmann O; Anand IS; Wu AH; Nowak R; Peacock WF; Ponikowski P; Mockel M; Hogan C; Filippatos GS; Di Somma S; Ng L; Neath SX; Christenson R; Morgenthaler NG; Anker SD; Maisel AS
    Eur J Heart Fail; 2012 Jan; 14(1):22-31. PubMed ID: 22140234
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Metabolic rather than body composition measurements are associated with lower serum natriuretic peptide concentrations in normal weight and obese men.
    Asferg CL; Nielsen SJ; Andersen UB; Linneberg A; Møller DV; Hedley PL; Christiansen M; Gøtze JP; Jeppesen JL
    Am J Hypertens; 2014 Apr; 27(4):620-7. PubMed ID: 24025723
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic value of midregional pro-atrial natriuretic peptide in ventilator-associated pneumonia.
    Seligman R; Papassotiriou J; Morgenthaler NG; Meisner M; Teixeira PJ
    Intensive Care Med; 2008 Nov; 34(11):2084-91. PubMed ID: 18523752
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The midregional fragment of pro-A-type natriuretic peptide, blood pressure, and mortality in a prospective cohort study of patients with type 2 diabetes (ZODIAC-25).
    van Hateren KJ; Landman GW; Kleefstra N; Groenier KH; Struck J; Navis GJ; Bakker SJ; Houweling ST; van der Meer K; Bilo HJ
    Diabetes Care; 2013 May; 36(5):1347-52. PubMed ID: 23230100
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [High levels of atrial natriuretic peptide and copeptin and mortality risk].
    Rey C; García-Cendón C; Martínez-Camblor P; López-Herce J; Concha-Torre A; Medina A; Vivanco-Allende A; Mayordomo-Colunga J
    An Pediatr (Barc); 2016 Dec; 85(6):284-290. PubMed ID: 26988235
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Midregional pro atrial natriuretic peptide: a novel important biomarker for noise annoyance-induced cardiovascular morbidity and mortality?
    Hahad O; Wild PS; Prochaska JH; Schulz A; Lackner KJ; Pfeiffer N; Schmidtmann I; Michal M; Beutel M; Daiber A; Münzel T
    Clin Res Cardiol; 2021 Jan; 110(1):29-39. PubMed ID: 32306084
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sensitivity and Specificity of Soluble Triggering Receptor Expressed on Myeloid Cells-1, Midregional Proatrial Natriuretic Peptide and Midregional Proadrenomedullin for Distinguishing Etiology and to Assess Severity in Community-Acquired Pneumonia.
    Esposito S; Di Gangi M; Cardinale F; Baraldi E; Corsini I; Da Dalt L; Tovo PA; Correra A; Villani A; Sacco O; Tenero L; Dones P; Gambino M; Zampiero A; Principi N;
    PLoS One; 2016; 11(11):e0163262. PubMed ID: 27846213
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Effect of a Life-Style Intervention Program of Diet and Exercise on Irisin and FGF-21 Concentrations in Children and Adolescents with Overweight and Obesity.
    Karampatsou SI; Genitsaridi SM; Michos A; Kourkouni E; Kourlaba G; Kassari P; Manios Y; Charmandari E
    Nutrients; 2021 Apr; 13(4):. PubMed ID: 33924457
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mid-regional proatrial natriuretic peptide for predicting prognosis in hypertrophic cardiomyopathy.
    Bégué C; Mörner S; Brito D; Hengstenberg C; Cleland JGF; Arbustini E; Galve E; Wichter T; Richter A; Golmard JL; Bernard M; Dubourg O; Komajda M; Charron P; Isnard R
    Heart; 2020 Feb; 106(3):196-202. PubMed ID: 31350276
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Midregional pro-atrial natriuretic peptide for the diagnosis of cardiac-related dyspnea according to renal function in the emergency department: a comparison with B-type natriuretic peptide (BNP) and N-terminal proBNP.
    Chenevier-Gobeaux C; Guerin S; André S; Ray P; Cynober L; Gestin S; Pourriat JL; Claessens YE
    Clin Chem; 2010 Nov; 56(11):1708-17. PubMed ID: 20813917
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevention of diabetes in overweight/obese children through a family based intervention program including supervised exercise (PREDIKID project): study protocol for a randomized controlled trial.
    Arenaza L; Medrano M; Amasene M; Rodríguez-Vigil B; Díez I; Graña M; Tobalina I; Maiz E; Arteche E; Larrarte E; Huybrechts I; Davis CL; Ruiz JR; Ortega FB; Margareto J; Labayen I
    Trials; 2017 Aug; 18(1):372. PubMed ID: 28793919
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Midregional pro-atrial natriuretic peptide in the general population/Insights from the Gutenberg Health Study.
    Tzikas S; Keller T; Wild PS; Schulz A; Zwiener I; Zeller T; Schnabel RB; Sinning C; Lubos E; Kunde J; Münzel T; Lackner KJ; Blankenberg S
    Clin Chem Lab Med; 2013 May; 51(5):1125-33. PubMed ID: 23183754
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Blood-based microcirculation markers in Alzheimer's disease-diagnostic value of midregional pro-atrial natriuretic peptide/C-terminal endothelin-1 precursor fragment ratio.
    Buerger K; Ernst A; Ewers M; Uspenskaya O; Omerovic M; Morgenthaler NG; Knauer K; Bergmann A; Hampel H
    Biol Psychiatry; 2009 Jun; 65(11):979-84. PubMed ID: 19344890
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Natriuretic Propeptides as Markers of Atrial Fibrillation Burden and Recurrence (from the AMIO-CAT Trial).
    Darkner S; Goetze JP; Chen X; Henningsen K; Pehrson S; Svendsen JH
    Am J Cardiol; 2017 Oct; 120(8):1309-1315. PubMed ID: 28865890
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.